Skip to content

Our publications

Since its inception, Inovarion has contributed to the completion of high-level research projects. Our scientists have actively participated to studies resulting in publications in prestigious, high-impact journals. These publications span a wide range of fields within biology, driving innovation and fostering progress across numerous therapeutic and scientific domains.

See all on Pubmed
Filter :
Eur Urol
Oncology

Proteogenomic Characterization of Bladder Cancer Reveals Sensitivity to Apoptosis Induced by Tumor Necrosis Factor-related Apoptosis-inducing Ligand in FGFR3-mutated Tumors

Learn more
International Journal of Molecular Sciences
Oncology

Benzo(a)pyrene and Cerium Dioxide Nanoparticles in Co-Exposure Impair Human Trophoblast Cell Stress Signaling

Learn more
Br J Cancer
Oncology

The Neuropilin-1/PKC axis promotes neuroendocrine differentiation and drug resistance of prostate cancer

Learn more
Eur Urol
Oncology

FGFR3 Mutational Activation Can Induce Luminal-like Papillary Bladder Tumor Formation and Favors a Male Sex Bias

Learn more
Cancers (Basel)
Oncology

Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study

Learn more
Frontiers in oncology
Oncology

Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies

Learn more
JCO precision oncology
Oncology

Immunoscore Is Prognostic in Low-Risk and High-Risk Stage III Colon Carcinomas Treated With Adjuvant Infusional Fluorouracil, Leucovorin, and Oxaliplatin in a Phase III Trial

Learn more
Cancer letters
Oncology

Predictive biomarkers for personalized medicine in breast cancer

Learn more
Frontiers in Immunology
Oncology

Dissecting the Role of AXL in Cancer Immune Escape and Resistance to Immune Checkpoint Inhibition

Learn more
Frontiers in Immunology
Oncology

The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes?

Learn more
Oncoimmunology
Oncology

Immune sunrise: from the immunome to the cancer immune landscape

Learn more
Cancer Research
Oncology

Allosteric inhibition of HER2 by Moesin-mimicking compounds targets HER2-positive cancers and brain metastases

Learn more